Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$9,297,587
+$1,310,022 QoQ
Shares Held
36,609
+12.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.47%
of 13F equity value
Holder Rank
#1,159
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAX WEALTH ADVISORS, LLC holds $21,617,283 across 11 Drug Manufacturers - General names. JNJ ranks #1 (43.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
36,609 | $9,297,587 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,762 | $3,824,417 | |
| 3 | ABBV |
AbbVie Inc.
|
11,579 | $2,913,739 | |
| 4 | LLY |
ELI LILLY & Co
|
1,529 | $1,833,928 | |
| 5 | NVO |
Novo Nordisk A S
|
21,893 | $1,049,550 | |
| 6 | BIIB |
Biogen Inc.
|
3,364 | $726,825 | |
| 7 | AMGN |
Amgen Inc
|
1,862 | $674,267 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,662 | $383,864 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,297,587 | 36,609 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $7,987,565 | 32,677 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $6,967,592 | 33,668 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $6,108,105 | 32,942 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $4,784,130 | 31,320 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,663,073 | 22,088 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,738,813 | 18,938 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $2,613,055 | 16,124 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,458,995 | 16,824 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,470,136 | 15,615 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,460,034 | 15,695 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,390,295 | 15,347 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,455,158 | 14,833 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,309,655 | 14,901 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,567,607 | 14,535 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,869,091 | 17,563 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,744,568 | 9,828 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $363,853 | 2,053 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $401,330 | 2,346 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $236,436 | 1,464 | Shares | Sole | 2021-12-10 | |
| 2021-06-30 | $217,951 | 1,323 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $217,106 | 1,321 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $202,390 | 1,286 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||